Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 89035250

CD34, anti-Human, Clone: HPCA1/1806R, Abnova™

Catalog No. 89035250 Shop All Abnova Corporation Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
89-035-250 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 89-035-250 Supplier Abnova Corporation Supplier No. RAB00371
Add to Cart
Add to Cart

Description

Monoclonal Antibody

Specifications

Antigen CD34
Applications Flow Cytometry, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Classification Monoclonal
Clone HPCA1/1806R
Conjugate Unconjugated
Dilution Flow Cytometry (0.5-1 ug/106 cells) Immunofluorescence (0.5-1 ug/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (2-4 ug/mL) Western Blotting (0.5-1 ug/mL) The optimal working dilution should be determined by the end user.
Formulation In 10 mM PBS (0.05% BSA, 0.05% sodium azide).
Gene CD34 molecule
Gene Alias -
Gene Symbols CD34
Immunogen Original antibody is raised against recombinant protein corresponding to full length human CD34.
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 947
Target Species Human
Content And Storage Store at 4°C.
Product Type Antibody
Form Liquid
Isotype IgG κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.